Yüklüyor......

(18)FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer

PURPOSE: To evaluate 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography imaging ((18)FDG-PET) as a predictive, non-invasive, pharmacodynamic (PD) biomarker of response following administration of a small-molecule IGF-1R/IR inhibitor, OSI-906. EXPERIMENTAL DESIGN: In vitro uptake studies...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: McKinley, Eliot T., Bugaj, Joseph E., Zhao, Ping, Guleryuz, Saffet, Mantis, Christine, Gokhale, Prafulla C., Wild, Robert, Manning, H. Charles
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122480/
https://ncbi.nlm.nih.gov/pubmed/21257723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2274
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!